---
document_datetime: 2023-09-21 17:26:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xeplion-epar-all-authorised-presentations_en.pdf
document_name: xeplion-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3406939
conversion_datetime: 2025-12-24 16:25:38.162868
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EU Number Invented Strength Pharmaceutical Form

name

Xeplion

Xeplion

Xeplion

Xeplion

Xeplion

Xeplion

EU/1/11/672/001

EU/1/11/672/002

EU/1/11/672/003

EU/1/11/672/004

EU/1/11/672/005

EU/1/11/672/006

25 mg          Prolonged release suspension for injection 50 mg          Prolonged release suspension for injection 75 mg          Prolonged release suspension for injection 100 mg        Prolonged release suspension for injection 150 mg        Prolonged release suspension for injection 150 mg, Prolonged release suspension for injection

100 mg

## Route of Administration Packaging Package size

Intramuscular use pre-filled syringe Intramuscular use pre-filled syringe Intramuscular use pre-filled syringe Intramuscular use pre-filled syringe Intramuscular use pre-filled syringe Intramuscular use pre-filled syringe

1 pre-filled syringe + 2 needles 1 pre-filled syringe + 2 needles 1 pre-filled syringe + 2 needles 1 pre-filled syringe + 2 needles 1 pre-filled syringe + 2 needles Initiation pack: 1 pre-filled syringe of 150 mg + 2 needles, 1 prefilled syringe 100 mg + 2 needles